MedTrace Logo

To Assess Efficacy of Epiitalis on Knee Pain in Patients Suffering From Knee Osteoarthritis

NCT04117490 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 237

Last updated 2022-02-01

No results posted yet for this study

Summary

Epiitalis is an ingredient of a currently marketed product named as Osteo-Restore, indicated for joint health.The present study is primarily planned to establish the role of Epiitalis as a single ingredient in the treatment of mild to moderate cases of knee Osteoarthritis.

Conditions

Interventions

OTHER

Epiitalis

Two capsules twice daily 30 mins before meals (breakfast \& dinner).

OTHER

Placebo

Two capsules twice daily 30 mins before meals (breakfast \& dinner).

Sponsors & Collaborators

  • Vedic Lifesciences Pvt. Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-12-12
Primary Completion
2020-10-21
Completion
2020-10-21

Countries

  • India

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04117490 on ClinicalTrials.gov